March 7, 2024

CATAWBA RESEARCH APPOINTS JULIE ARNOLD AS NEW HEAD OF PROJECT MANAGEMENT TO DRIVE GROWTH AND INNOVATION

CHARLOTTE, N.C.; March 7, 2024 (Business Wire) – Catawba Research, a prominent global clinical research organization (CRO), today introduced Julie Arnold as its vice president of project management. The continued addition of top-tier talent to the leadership team exemplifies Catawba Research’s unwavering commitment to partnering in the advancement of groundbreaking new drugs, devices and diagnostics. 

With a 20-year career, distinguished by leadership across multiple therapeutic areas, Julie is a pivotal addition to Catawba Research’s growing operational team. Previously the Senior Vice President of Project Management at Elligo Health Research ® and holding key roles at Syneos Health, Julie’s experience strategically positions her to optimize Catawba Research’s clinical and project management teams and processes — ensuring a seamless continuation of quality-driven, on-time project delivery.

“I couldn’t be more excited about the addition of Julie to our leadership team. Her outstanding track record of project leadership and her strategic prowess align seamlessly with our vision for the future. By bringing in talented leaders like Julie, Catawba Research is poised for continued growth, consistently exceeding our customers’ expectations,” said Andy Silverman , Ph.D., CEO at Catawba Research.

In her role, Julie will be dedicated to ensuring operational efficiency and supporting the continued and successful project outcomes that have been at the core of Catawba Research’s industry reputation for the past decade. Her expertise and oversight are set to play a pivotal role in the company’s mission to bring groundbreaking therapies to underserved populations through continuous innovation and collaborative partnerships with sponsors, vendors and sites.

About Catawba Research 
Catawba Research is a leading contract research organization specializing in clinical research and development services for the pharmaceutical, biotechnology, and medical device industries. With a strong commitment to quality, innovation, and client satisfaction, Catawba Research delivers comprehensive solutions to advance healthcare products from concept to market. For more information, please visit www.catawbaresearch.com. 

Won’t you get hip to this kindly tip, get your kicks on Route 505(b)(2). What is that?Route 505(b)(2) vs. 505(j)Altasciences Acquires WCCT Global“ This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopAn Overview of GDUFAThe Office of Generic Drugs (OGD) reports directly to the Director of the Center for Drug Evaluation and Research (CDER). The OGD’s mission is to ensure safe, effective, and affordable medicines for the American public.Catawba Research Concludes Another Rosacea Clinical TrialCatawba Research is pleased to announce another achievement for a recently completed rosacea clinical trial. In this trial, Catawba enrolled more than 1000 rosacea subjects in 22 weeks from 33 sites .Catawba Research Achieves Acne First-to-FileThe team at Catawba Research has recently completed a first-to-file submission for acne clinical trial . In this study, Catawba enrolled a staggering 1125 acne vulgaris subjects in 8 weeks from 12 sites .Catawba Research Adds Tinea Pedis Video to Training LibraryTo learn more about our training program or see some our videos, contact us !